Diadema Partners »

Tenax Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 243k 12.19

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Tenax Therapeutics

Ikarian Capital
Siren
Point72 Asset Management
Rtw Investments
Boothbay Fund Management
BVF
Millennium Management
Marshall Wace
Vanguard Group
Diadema Partners
Vivo Capital
Sphera Funds Management
Integral Health Asset Management
Henderson Group
Woodline Partners

View all funds holding Tenax Therapeutics